| N.V. Organon |
Ioa |
G03AA14 | nomegestrol acetate / estradiol |
| N.V. Organon |
Sycrest |
N05AH05 | asenapine maleate |
| N.V. ORGANON |
Mercilon - tabl 0,15mg 0,02mg n63; n21 |
G03AA09 | Desogestrel Ethinylestradiol |
| N.V. ORGANON |
Esmeron - inj / inf lahus 10mg / 1ml 10ml n10; 2,5ml n10; 5ml n10; 5ml n12 |
M03AC09 | Rocuronium bromide |
| N.V. Organon |
Nuvaring - vaginaalravivahend (11,7mg +2,7mg) |
G02BB01 | etonogestreel +etünüülöstradiool |
| N.V. ORGANON |
Remeron soltab - suus dispergeeruv tabl 30mg n6; n18; n30; n48; n96 |
N06AX11 | Mirtazapine |
| N.V. ORGANON |
Remeron soltab - suus dispergeeruv tabl 15mg n6; n18; n30; n48; n96 |
N06AX11 | Mirtazapine |
| N.V. ORGANON |
Marvelon - tabl 0,15mg 0,03mg n21; n21x3 |
G03AA09 | Desogestrel Ethinylestradiol |
| Narodowe Centrum Bada? J?drowych |
Tektrotyd - radiofarmatseutiline komplekt (20mcg) |
V09IA07 | tehneetsium(99mTc)HYNIC-oktreotiid |
| Neovii Biotech GmbH |
REMOVAB |
L01XC09 | catumaxomab |
| Neovii Biotech GmbH |
Grafalon - inf conc 20mg / ml 5ml n10 |
L04AA04 | Rabbit anti-T-lymphocyte immunoglobulin |
| Neovii Biotech GmbH |
Grafalon - infusioonilahuse kontsentraat (20mg 1ml) |
L04AA04 | küüliku anti-T-lümfotsüütne immunoglobuliin |
| Newline Pharma, S.L. |
Ipratropium bromide newline pharma - inhalatsiooniaerosool, lahus (20mcg 1pihustus) |
R03BB01 | ipratroopiumbromiid |
| NOD Europe Ltd |
Maqs - taru ravimriba (68,2g 1riba) |
QP53AG01 | sipelghape |
| Norbrook Laboratories Limited |
Alamycin - nahasprei, lahus (32,1mg 1g) |
QD06AA03 | oksütetratsükliin |
| Norbrook Laboratories Limited |
Alamycin 10 - süstelahus (100mg 1ml) |
QJ01AA06 | oksütetratsükliin |
| Norbrook Laboratories Limited |
Alamycin la - süstelahus (200mg 1ml) |
QJ01AA06 | oksütetratsükliin |
| Norbrook Laboratories Limited |
Betafuse - geel (1mg +5mg 1g) |
QD07CC01 | beetametasoon +fusidiinhape |
| Norbrook Laboratories Limited |
Betamox la - süstesuspensioon (150mg 1ml) |
QJ01CA04 | amoksitsilliin |
| Norbrook Laboratories Limited |
Bovaclox dc - intramammaarsuspensioon (250mg +500mg 1annust) |
QJ51RC85 | ampitsilliin +kloksatsilliin |
| Norbrook Laboratories Limited |
Carprieve 100 mg - tablett (100mg) |
QM01AE91 | karprofeen |
| Norbrook Laboratories Limited |
Carprieve 20 mg - tablett (20mg) |
QM01AE91 | karprofeen |
| Norbrook Laboratories Limited |
Carprieve 50 mg - tablett (50mg) |
QM01AE91 | karprofeen |
| Norbrook Laboratories Limited |
Cefenil - süstelahuse pulber ja lahusti (50mg 1ml) |
QJ01DD90 | tseftiofuur |
| Norbrook Laboratories Limited |
Cefenil rtu - süstesuspensioon (50mg 1ml) |
QJ01DD90 | tseftiofuur |
| Norbrook Laboratories Limited |
Cefimam dc - intramammaarsalv (150mg 3g) |
QJ51DE90 | tsefkvinoom |
| Norbrook Laboratories Limited |
Cefimam lc - intramammaarsalv (75mg 8g) |
QJ51DE90 | tsefkvinoom |
| Norbrook Laboratories Limited |
Cepritect - intramammaarsuspensioon (250mg 3g) |
QJ51DB90 | tsefaloonium |
| Norbrook Laboratories Limited |
Eprizero - kriipsulahus (5mg 1ml) |
QP54AA04 | eprinomektiin |
| Norbrook Laboratories Limited |
Intraseal - intramammaarsuspensioon (2,6g 4g) |
QG52XX80 | vismutsubnitraat |
| Norbrook Laboratories Limited |
Lactaclox - intramammaarsuspensioon (10,71mg +28,57mg 1ml) |
QJ51RC85 | ampitsilliin +kloksatsilliin |
| Norbrook Laboratories Limited |
Marbodex - kõrvatilgad, suspensioon (0,9mg +3mg +10mg 1ml) |
QS02CA85 | deksametasoon +marbofloksatsiin +klotrimasool |
| Norbrook Laboratories Limited |
Marbonor - süstelahus (100mg 1ml) |
QJ01MA93 | marbofloksatsiin |
| Norbrook Laboratories Limited |
Multivitamin injection - süstelahus (25mg +1000rü +35mg +3mg +15000rü +5mg +10mg +20mg +50mcg 1ml) |
QA11JA89 | retinool +tokoferool +nikotiinamiid +riboflaviin +dekspantenool +tsüanokobalamiin +kolekaltsiferool +püridoksiin +tiamiin |
| Norbrook Laboratories Limited |
Norador - kriipsulahus (5mg 1ml) |
QP54AA03 | doramektiin |
| Norbrook Laboratories Limited |
Norocarp injection - süstelahus (50mg 1ml) |
QM01AE91 | karprofeen |
| Norbrook Laboratories Limited |
Norocillin - süstesuspensioon (300mg 1ml) |
QJ01CE09 | prokaiinbensüülpenitsilliin |
| Norbrook Laboratories Limited |
Noroclav - intramammaarsuspensioon (200mg +10mg +50mg 3g) |
QJ51RV90 | amoksitsilliin +prednisoloon +klavulaanhape |
| Norbrook Laboratories Limited |
Noroclav 250 mg - tablett (200mg +50mg) |
QJ01CR80 | amoksitsilliin +klavulaanhape |
| Norbrook Laboratories Limited |
Noroclav 50 mg - tablett (40mg +10mg) |
QJ01CR80 | amoksitsilliin +klavulaanhape |
| Norbrook Laboratories Limited |
Noroclav 500 mg - tablett (400mg +100mg) |
QJ01CR80 | amoksitsilliin +klavulaanhape |
| Norbrook Laboratories Limited |
Noroclav injection - süstesuspensioon (140mg +35mg 1ml) |
QJ01CR80 | amoksitsilliin +klavulaanhape |
| Norbrook Laboratories Limited |
Noroclox dc - intramammaarsuspensioon (500mg 1annust) |
QJ51CF02 | kloksatsilliin |
| Norbrook Laboratories Limited |
Norodine 24 - süstelahus (200mg +40mg 1ml) |
QJ01EW10 | sulfadiasiin +trimetoprim |
| Norbrook Laboratories Limited |
Noromectin duo - suukaudne pasta (18,7mg +140,3mg 1g) |
QP54AA82 | ivermektiin +prasikvanteel |
| Norbrook Laboratories Limited |
Noromectin multi injection - süstelahus (10mg 1ml) |
QP54AA01 | ivermektiin |
| Norbrook Laboratories Limited |
Norotril max - süstelahus (100mg 1ml) |
QJ01MA90 | enrofloksatsiin |
| Norbrook Laboratories Limited |
Norotyl la - süstesuspensioon (150mg 1ml) |
QJ01FA90 | tülosiin |
| Norbrook Laboratories Limited |
Pen & strep - süstesuspensioon (200mg +250mg 1ml) |
QJ01RA75 | prokaiinbensüülpenitsilliin +dihüdrostreptomütsiin |
| Norbrook Laboratories Limited |
Peptizole - suukaudne pasta (370mg 1g) |
QA02BC01 | omeprasool |
| Norbrook Laboratories Limited |
Pestigon - nahasprei, lahus (2,5mg 1ml) |
QP53AX15 | fiproniil |
| Norbrook Laboratories Limited |
Pestigon - täpilahus (268mg 2.68ml) |
QP53AX15 | fiproniil |
| Norbrook Laboratories Limited |
Pestigon - täpilahus (50mg 0.5ml) |
QP53AX15 | fiproniil |
| Norbrook Laboratories Limited |
Pestigon - täpilahus (67mg 0.67ml) |
QP53AX15 | fiproniil |
| Norbrook Laboratories Limited |
Pestigon - täpilahus (134mg 1.34ml) |
QP53AX15 | fiproniil |
| Norbrook Laboratories Limited |
Pestigon - täpilahus (402mg 4.02ml) |
QP53AX15 | fiproniil |
| Norbrook Laboratories Limited |
Pestigon combo - täpilahus (402mg +361,8mg 4.02ml) |
QP53AX80 | fiproniil +metopreen |
| Norbrook Laboratories Limited |
Pestigon combo - täpilahus (67mg +60,3mg 0.67ml) |
QP53AX80 | fiproniil +metopreen |
| Norbrook Laboratories Limited |
Pestigon combo - täpilahus (50mg +60mg 0.5ml) |
QP53AX80 | fiproniil +metopreen |
| Norbrook Laboratories Limited |
Pestigon combo - täpilahus (268mg +241,2mg 2.68ml) |
QP53AX80 | fiproniil +metopreen |
| Norbrook Laboratories Limited |
Pestigon combo - täpilahus (134mg +120,6mg 1.34ml) |
QP53AX80 | fiproniil +metopreen |
| Norbrook Laboratories Limited |
Spotinor - täpilahus (10mg 1ml) |
QP53AC11 | deltametriin |
| Norbrook Laboratories Limited |
Taurador - kriipsulahus (5mg 1ml) |
QP54AA03 | doramektiin |
| Norbrook Laboratories Limited |
Ultrapen la - süstesuspensioon (300mg 1ml) |
QJ01CE09 | prokaiinbensüülpenitsilliin |
| Norbrook Laboratories Limited |
Vetofol - süsteemulsioon (10mg 1ml) |
QN01AX10 | propofool |
| Nordic Group BV |
Teysuno |
L01BC53 | tegafur / gimeracil / oteracil |
| Nordic Group BV |
Mifegyne - tablett (200mg) |
G03XB01 | mifepristoon |
| Nordic Group BV |
Topogyne - tablett (400mcg) |
G02AD06 | misoprostool |
| NORDIC Pharma s.r.o. |
Veregen - salv (100mg 1g) |
D06BB12 | sinekatehhiinid |
| Norgine BV |
Savene |
V03AF02 | dexrazoxane hydrochloride |
| Norgine BV |
Moviprep - suukaudse lahuse pulber (100g +7,5g +2,691g +1,015g +0 +0/0 +0 +0 +0 +4,7g +5,9g) |
A06AD83 | makrogool +naatriumsulfaat, veevaba +naatriumkloriid +kaaliumkloriid +askorbiinhape +naatriumaskorbaat |
| Norgine Limited |
Moviprep - suukaudse lahuse pulber 100g 7,5g 2,691g 1,015g (kotike 1) 4,7g 5,9g (kotike 2) n1;n10;n40;n80;n160;n320 |
A06AD83 | Macrogol Sodium sulphate, anhydrous Sodium chloride Potassium chloride Ascorbic acid Sodium ascorbate |
| Norpharm Regulatory Services Ltd |
Paracetamolascorbic acidpheniramine norpharm - suukaudse lahuse gran 500mg 200mg 25mg n6; n8 |
N02BE85 | Paracetamol Pheniramine Ascorbic acid |
| Norpharm Regulatory Services Ltd |
Paracetamolascorbic acidpheniramine norpharm - suukaudse lahuse graanulid (500mg +25mg +200mg) |
N02BE85 | paratsetamool +feniramiin +askorbiinhape |
| Nova Laboratories Ltd. |
Xaluprine (previously Mercaptopurine Nova Laboratories) |
L01BB02 | 6-mercaptopurine monohydrate |
| Novartis Europharm Limited |
Aclasta |
M05BA08 | zoledronic acid |
| Novartis Europharm Limited |
Exforge |
C09DB01 | amlodipine / valsartan |
| Novartis Europharm Limited |
Exforge HCT |
C09DX01 | amlodipine besylate / valsartan / hydrochlorothiazide |
| Novartis Europharm Limited |
Exjade |
V03AC03 | deferasirox |
| Novartis Europharm Limited |
GALVUS |
A10BH02 | vildagliptin |
| Novartis Europharm Limited |
Zelnorm |
A03AE02 | tegaserod |
| Novartis Europharm Ltd |
Enurev Breezhaler |
R03BB06 | glycopyrronium bromide |
| Novartis Europharm Ltd |
Eucreas |
A10BD08 | vildagliptin / metformin hydrochloride |
| Novartis Europharm Ltd |
Ilaris |
L04AC08 | canakinumab |
| Novartis Europharm Ltd |
Jalra |
A10BH02 | vildagliptin |
| Novartis Europharm Ltd |
Lucentis |
S01LA04 | ranibizumab |
| Novartis Europharm Ltd |
Ultibro Breezhaler |
R03AL04 | indacaterol / glycopyrronium bromide |
| Novartis Europharm Ltd |
Xolair |
R03DX05 | omalizumab |
| Novartis Europharm Ltd |
Xoterna Breezhaler |
R03AL04 | indacaterol / glycopyrronium bromide |
| Novartis Europharm Ltd.
|
Onbrez Breezhaler |
R03AC18 | indacaterol maleate |
| Novartis Europharm Ltd.
|
Tobi Podhaler |
J01GB01 | tobramycin |
| Novartis Europharm Ltd.
|
Oslif Breezhaler |
R03AC18 | indacaterol maleate |
| Novartis Europharm Ltd. |
Afinitor |
L01XE10 | everolimus |
| Novartis Europharm Ltd. |
Comtan |
N04BX02 | entacapone |
| Novartis Europharm Ltd. |
Copalia |
C09DB01 | amlodipine / valsartan |
| Novartis Europharm Ltd. |
Copalia HCT |
C09DX01 | amlodipine / valsartan / hydrochlorothiazide |
| Novartis Europharm Ltd. |
Cubicin |
J01XX09 | daptomycin |
| Novartis Europharm Ltd. |
Dafiro |
C09DB01 | amlodipine / valsartan |
| Novartis Europharm Ltd. |
Dafiro HCT |
C09DX01 | amlodipine besylate / valsartan / hydrochlorothiazide |
| Novartis Europharm Ltd. |
ENVIAGE |
C09XA02 | aliskiren |
| Novartis Europharm Ltd. |
Exelon |
N06DA03 | rivastigmine |
| Novartis Europharm Ltd. |
Extavia |
L03AB08 | interferon beta-1b |
| Novartis Europharm Ltd. |
Gilenya |
L04AA27 | fingolimod hydrochloride |
| Novartis Europharm Ltd. |
Glivec |
L01XE01 | imatinib |
| Novartis Europharm Ltd. |
Hirobriz Breezhaler |
R03AC18 | indacaterol maleate |
| Novartis Europharm Ltd. |
Icandra (previously Vildagliptin / metformin hydrochloride Novartis) |
A10BD08 | vildagliptin / metformin hydrochloride |
| Novartis Europharm Ltd. |
Imprida HCT |
C09DB03 | amlodipine / valsartan / hydrochlorothiazide |
| Novartis Europharm Ltd. |
Prometax |
N06DA03 | rivastigmine |
| Novartis Europharm Ltd. |
Rasilamlo |
C09XA53 | aliskiren / amlodipine |
| Novartis Europharm Ltd. |
RASILEZ HCT |
C09XA52 | aliskiren / hydrochlorothiazide |
| Novartis Europharm Ltd. |
Sebivo |
J05AF11 | telbivudine |
| Novartis Europharm Ltd. |
Seebri Breezhaler |
R03BB06 | glycopyrronium bromide |
| Novartis Europharm Ltd. |
Signifor |
H01CB05 | pasireotide diaspartate |
| Novartis Europharm Ltd. |
Simulect |
L04AC02 | basiliximab |
| Novartis Europharm Ltd. |
Sprimeo |
C09XA02 | aliskiren |
| Novartis Europharm Ltd. |
Starlix |
A10BX03 | nateglinide |
| Novartis Europharm Ltd. |
Tasigna |
L01XE08 | nilotinib |
| Novartis Europharm Ltd. |
Tovanor Breezhaler |
R03BB06 | glycopyrronium bromide |
| Novartis Europharm Ltd. |
Trazec |
A10BX03 | nateglinide |
| Novartis Europharm Ltd. |
Visudyne |
S01LA01 | verteporfin |
| Novartis Europharm Ltd. |
Votubia |
L01XE10 | everolimus |
| Novartis Europharm Ltd. |
Xiliarx |
A10BH02 | vildagliptin |
| Novartis Europharm Ltd. |
Zomarist |
A10BD08 | vildagliptin / metformin hydrochloride |
| Novartis Europharm Ltd. |
Zometa |
M05BA08 | zoledronic acid |
| Novartis Europharm Ltd. |
Jakavi |
L01XE18 | ruxolitinib (as phosphate) |
| Novartis Finland OY |
Otrivin - ninasprei, lahus 1mg / 1ml 10ml n1 |
R01AA07 | Xylometazoline |
| Novartis Finland OY |
Voltaren emulgel - geel 10mg / g 20g; 50g; 100g; 50ml; 75ml |
M02AA15 | Diclofenac |
| Novartis Finland OY |
Voltaren - ravimplaaster 140mg n2; n5; n10 |
M02AA15 | Diclofenac |
| Novartis Finland OY |
Cataflam - kaetud tablett (50mg) |
M01AB05 | diklofenak |
| Novartis Finland OY |
Miflonide - inhal. pulber kapslis 200mcg n60 |
R03BA02 | Budesonide |
| Novartis Finland OY |
Miflonide - inhal. pulber kapslis 400mcg n60 |
R03BA02 | Budesonide |
| Novartis Finland OY |
Lamisil - kreem 10mg / g 15g n1 |
D01AE15 | Terbinafine |
| Novartis Finland OY |
Lamisil - nahasprei, lahus 10mg / g 15ml n1 (k); 30ml n1 (r) |
D01AE15 | Terbinafine |
| Novartis Finland OY |
Sandostatin - inj 0,1mg / ml amp 1ml n5 |
H01CB02 | Octreotide |
| Novartis Finland OY |
Tavegyl - inj 1mg / ml 2ml n5 |
R06AA04 | Clemastine |
| Novartis Finland OY |
Venoruton - geel 20mg / g 40g n1 |
C05CA01 | Rutoside |
| Novartis Finland OY |
Fenivir - kreem 10mg / g 2g |
D06BB06 | Penciclovir |
| Novartis Finland OY |
Diovan - suukaudne lahus 3mg / 1ml 160ml n1 |
C09CA03 | Valsartan |
| Novartis Finland OY |
Miflonide breezhaler - inhalatsioonipulber kõvakapslis (200mcg) |
R03BA02 | budesoniid |
| Novartis Finland OY |
Miflonide breezhaler - inhalatsioonipulber kõvakapslis (400mcg) |
R03BA02 | budesoniid |
| Novartis Vaccines and Diagnostics GmbH |
Optaflu |
J07BB02 | Influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:
A/California/7/2009 (H1N1)pdm09 - like strain used A/Brisbane/10/2010 wild type Victoria/361/2011 (H3N2) - like strain used (NYMC X-223A) derived from A/Texas/50/2012 B/Massachusetts/2/2012 |
| Novartis Vaccines and Diagnostics S.r.l.
|
Aflunov |
J07BB02 | influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23) |
| Novartis Vaccines and Diagnostics S.r.l. |
Bexsero |
J07AH09 | recombinant Neisseria meningitidis group-B NHBA fusion protein /recombinant Neisseria meningitidis group-B NadA protein /recombinant Neisseria meningitidis group B fHbp fusion protein /outer membrane vesiclesfrom Neisseria meningitidis group B strain NZ98/254 measured as amount of total protein containing the PorA P1.4 |
| Novartis Vaccines and Diagnostics S.r.l. |
Focetria |
J07BB02 | Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 7.5 microgragms per 0.5 ml dose |
| Novartis Vaccines and Diagnostics S.r.l. |
Menveo |
J07AH08 | meningococcal group A, C, W-135 and Y conjugate vaccine |
| Novartis Vaccines and Diagnostics S.r.l. |
Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics |
J07BB02 | influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/Viet Nam/1194/2004 (H5N1) |
| Novo Nordisk A/S |
Actraphane |
A10AD01 | insulin human |
| Novo Nordisk A/S |
Actrapid |
A10AB01 | human insulin |
| Novo Nordisk A/S |
Insulatard |
A10AC01 | insulin human |
| Novo Nordisk A/S |
Levemir |
A10AE05 | insulin detemir |
| Novo Nordisk A/S |
Mixtard |
A10AD01 | insulin human |
| Novo Nordisk A/S |
NovoMix |
A10AD05 | insulin aspart |
| Novo Nordisk A/S |
NovoNorm |
A10BX02 | repaglinide |
| Novo Nordisk A/S |
NovoRapid |
A10AB05 | insulin aspart |
| Novo Nordisk A/S |
NovoThirteen |
B02BD11 | catridecacog |
| Novo Nordisk A/S |
Prandin |
A10BX02 | repaglinide |
| Novo Nordisk A/S |
Protaphane |
A10AC01 | insulin human |
| Novo Nordisk A/S |
Ryzodeg |
A10AD06 | insulin degludec / insulin aspart |
| Novo Nordisk A/S |
Tresiba |
A10AE06 | insulin degludec |
| Novo Nordisk A/S |
Victoza |
A10BX07 | liraglutide |
| Novo Nordisk A/S |
Kliogest - õhukese polümeerikattega tablett (1mg +2mg) |
G03FA01 | noretisteroon +östradiool |
| Novo Nordisk A/S |
Glucagen 1mg hypokit - süstelahuse pulber ja lahusti (1mg) |
H04AA01 | glükagoon |
| Novo Nordisk A/S |
Novofem - tabl 1mg 1mg / 1mg n28; 3 x n28 |
G03FB05 | Norethisterone Estradiol |
| Novo Nordisk A/S |
Eviana - õhukese polümeerikattega tablett (0,1mg +0,5mg) |
G03FA01 | noretisteroon +östradiool |
| Novo Nordisk A/S |
Estrofem - õhukese polümeerikattega tablett (1mg) |
G03CA03 | östradiool |
| Novo Nordisk A/S |
Trisequens - tabl 1mg n6;1mg 2mg n10; 2mg n12 (n28) |
G03FB05 | Norethisterone Estradiol |
| Novo Nordisk A/S |
Vagifem - vagin tabl 25mcg n5x3 |
G03CA03 | Estradiol |
| Novo Nordisk A/S |
Vagifem - vaginaaltablett (10mcg) |
G03CA03 | östradiool |
| Novo Nordisk A/S |
Novofem - õhukese polümeerikattega tablett (1mg +1mg/0 +1mg) |
G03FB05 | noretisteroon +östradiool |
| Novo Nordisk A/S |
Trisequens - õhukese polümeerikattega tablett (0 +1mg/1mg +2mg/0 +2mg) |
G03FB05 | noretisteroon +östradiool |
| NPS Pharma Holdings Limited |
Preotact |
H05AA03 | parathyroid hormone (rDNA) |
| NPS Pharma Holdings Limited |
Revestive |
A16AX08 | teduglutide |
| NTC S.r.l. |
Latanoprost ntc - silmatilgad, lahus 50mcg / 1ml 2,5ml n1; 2,5ml n3; 2,5ml n6 |
S01EE01 | Latanoprost |
